Table 1.
Baseline demographic and clinical characteristics of advanced gastric cancer patients
| Characteristic | Control, N=203; n (%) | Immunotherapy, N=71; n (%) | P-value |
|---|---|---|---|
| Age (years) | |||
| Mean | 57 | 54 | |
| Minimum | 23 | 32 | |
| Maximum | 86 | 75 | |
| Sex | 0.114 | ||
| Male | 137 (67.5) | 55 (77.5) | |
| Female | 66 (32.5) | 16 (22.5) | |
| Tumor site | 0.506 | ||
| Gastric cardia | 50 (24.6) | 22 (31.0) | |
| Gastric body | 100 (49.2) | 30 (42.3) | |
| Gastric antrum | 53 (26.2) | 19 (26.7) | |
| Tumor size (cm) | 0.498 | ||
| <5 | 140 (69.0) | 52 (73.2) | |
| ≥5 | 63 (31.0) | 19 (26.8) | |
| Differentiation | 0.746 | ||
| Well/moderate | 116 (57.1) | 39 (54.9) | |
| Poor | 87 (42.9) | 32 (45.1) | |
| Clinical stage | 0.568 | ||
| III | 139 (68.5) | 46 (64.8) | |
| IV | 64 (31.5) | 25 (35.2) | |
| Surgical procedure performed | 0.816 | ||
| Radical | 89 (43.8) | 30 (42.3) | |
| Palliative | 114 (56.2) | 41 (57.7) | |